Annaliesa Anderson, Ph.D., Will Lead Pfizer’s Vaccine Research & Development
The Pharma Data
JUNE 1, 2022
has been appointed Senior Vice President and Head of the Company’s Vaccine Research & Development (R&D) organization effective August 1, succeeding Kathrin U. Annaliesa is a world-class scientist with a track record of delivering both vaccines and therapeutics in pioneering new areas of science and where there is urgent unmet need.
Let's personalize your content